Interestingly, COVID-19 patients who develop severe disease have a complex maladapted immune profile that is accompanied by an increase in cytokines, such as IL-6, along with higher type-1 (e.g. IL-12) and type-2 cytokine (e.g. IL-5) levels [17]. The gene discussed is IL6; the disease is COVID-19.